ACTOLOG

Welcome to the Brand page for “ACTOLOG”, which is offered here for Conducting research and clinical trials relating to the use and the engineering of t-cells and cancer treatment and therapy;.

Its status is currently believed to be active. Its class is unavailable. “ACTOLOG” is believed to be currently owned by “immatics biotechnologies GmbH”.


Owner:
IMMATICS BIOTECHNOLOGIES GMBH
Owner Details
Description:
Conducting research and clinical trials relating to the use and the engineering of t-cells and cancer treatment and therapy;
Categories: CONDUCTING RESEARCH CLINICAL TRIALS